12-Mar-2010
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
About
|
Faculty Member List
|
Associate FMs
|
F1000 Reports
Search
All F1000
Oncology
Browse
ALL OF MEDICINE
Oncology
Breast Diseases: Benign & Malignant
Cancer in the Elderly
Genitourinary Cancers
Gynecological Cancers
Head & Neck Cancers
Oncology Agents
Pediatric Oncology
Sarcomas
Supportive & Palliative Cancer Care
Related Sections
Adrenal Cortex
Gastrointestinal Cancers
Leukemia & Proliferative Disorders of Hematic Cells
Lung Cancer
Lymphomas & Myelomas
Multiple Endocrine Disorders & Neoplasias
Neuro-Oncology
Skin Cancers (inc. Melanoma & Lymphoma)
selected for
My F1000
Browse > Oncology
Current Top 10 by F1000 Factor
/
All Time Top 10 by F1000 Factor
/
Most viewed
(from all journals)
/
Most viewed
(from specialty journals)
/
Hidden jewels
Page 1 of 81. Select Page:
1
2
3
4
5
6
7
8
9
10
>>
Display
10
/
20
/
50
papers per page
printer friendly
10 per page
20 per page
50 per page
any date
past 7d
past 14d
past 30d
past 60d
past 90d
past 180d
past 1y
past 2y
past 5y
all papers
hypotheses
new findings
confirmations
tech advances
controversial
refutation
dissenting
new on F1000
newly evaluated
F1000 factor
most evaluations
this page
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Recommended
F1000 Factor
3.0
Confirmation
A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
Heuer R, Gill IS, …, Richie JP, de la Rosette JJ
Eur Urol
2010 Feb
57
(2):223-32 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Hassan Wazait and Noor Buchholz
Evaluated 11 Mar 2010
Recommended
F1000 Factor
3.0
Confirmation
Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk.
Tang P, Sun L, …, Donatucci CF, Moul JW
J Urol
2010 Mar
183
(3):946-50 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| George Huang
Evaluated 11 Mar 2010
Recommended
F1000 Factor
3.0
New Finding
Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.
Nathan H, Raut CP, …, Choti MA, Pawlik TM
Ann Surg
2009 Dec
250
(6):970-6 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Richard Riedel
Evaluated 10 Mar 2010
Recommended
F1000 Factor
3.0
New Finding
Thrombosis in primary myelofibrosis: incidence and risk factors.
Barbui T, Carobbio A, …, Finazzi G, Barosi G
Blood
2010 Jan 28
115
(4):778-82 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Pierre Villeneuve and Armand Keating
Evaluated 10 Mar 2010
Exceptional
F1000 Factor
9.0
New Finding
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.
Qin Y, Yao L, …, Aguiar RC, Dahia PL
Nat Genet
2010 Mar
42
(3):229-33 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Tobias Carling
Evaluated 10 Mar 2010
Recommended
F1000 Factor
3.0
New Finding
Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma.
Morschhauser F, Marlton P, …, Brennan B, Mendila M
Ann Oncol
2010 Feb 15 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Nicolas Mounier
Evaluated 9 Mar 2010
Must Read
F1000 Factor
6.0
New Finding
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?
Mabe K, Takahashi M, …, Takeda H, Kawata S
World J Gastroenterol
2009 Sep 14
15
(34):4290-7 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Seiji Shiota and Yoshio Yamaoka
Evaluated 8 Mar 2010
Must Read
F1000 Factor
6.0
Changes
Clinical Practice
Confirmation
Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients.
Gastrointestinal Stromal Tumor Meta-Analysis Group (metaGIST)
J Clin Oncol
2010 Mar 1
28
:1247-53 [
abstract on PubMed
] [
related articles
] [
order article
]
Selected by
| Florence Duffaud
Evaluated 8 Mar 2010
Recommended
F1000 Factor
3.0
Confirmation
Influence of hydrocortisone dosage scheme on health related quality of life in patients with adrenal insufficiency.
Bleicken B, Hahner S, …, Allolio B, Quinkler M
Clin Endocrinol (Oxf)
2009 Mar 28
72
[
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Miguel Debono and John Newell-Price
Evaluated 5 Mar 2010
Recommended
F1000 Factor
3.0
New Finding
Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma.
Bruynzeel H, Feelders RA, …, de Herder WW, Kazemier G
J Clin Endocrinol Metab
2010 Feb
95
(2):678-85 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Marie Freel and Eleanor Davies
Evaluated 5 Mar 2010
top of page
Page 1 of 81. Select Page:
1
2
3
4
5
6
7
8
9
10
>>
Display
10
/
20
/
50
papers per page
© 2010 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info